Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/30/16 → 3/30/22 |
Funding
- PPD Development (Prot #AG-221-AML-004 // Prot #AG-221-AML-004)
- Celgene Corporation (Prot #AG-221-AML-004 // Prot #AG-221-AML-004)
Prot #AG-221-AML-004: A Phase 3, Multicenter, Open-label, Randomized Study Comparing the Efficacy and Safety of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogen
- Frankfurt, Olga (PD/PI)
Project: Research project